Literature DB >> 31002177

High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex.

Kiril Trpkov1, Michael Bonert2, Yuan Gao1, Anil Kapoor3, Huiying He4, Asli Yilmaz1, Anthony J Gill5, Sean R Williamson6, Eva Comperat7, Maria Tretiakova8, Cristina Magi-Galluzzi9, Fadi Brimo10, Ondrej Hes11.   

Abstract

Entities:  

Keywords:  hybrid; unclassified oncocytic tumour; kidney; unclassified renal tumour

Year:  2019        PMID: 31002177     DOI: 10.1111/his.13876

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  13 in total

Review 1.  [Oncocytic tumours of the kidney-new differential diagnoses].

Authors:  I Polifka; R Ohashi; H Moch
Journal:  Pathologe       Date:  2021-09-01       Impact factor: 1.011

2.  Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney.

Authors:  Payal Kapur; Ming Gao; Hua Zhong; Suneetha Chintalapati; Midori Mitui; Spencer D Barnes; Qinbo Zhou; Jeffrey Miyata; Deyssy Carrillo; Venkat S Malladi; Dinesh Rakheja; Ivan Pedrosa; Lin Xu; Lisa Kinch; James Brugarolas
Journal:  Mod Pathol       Date:  2021-09-20       Impact factor: 8.209

3.  Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Sean R Williamson; Anthony J Gill; Ondrej Hes; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-02-01       Impact factor: 7.842

Review 4.  Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss.

Authors:  Payal Kapur; Ming Gao; Hua Zhong; Dinesh Rakheja; Qi Cai; Ivan Pedrosa; Vitaly Margulis; Lin Xu; Lisa Kinch; James Brugarolas
Journal:  Adv Anat Pathol       Date:  2021-07-01       Impact factor: 4.571

Review 5.  Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities.

Authors:  Ondrej Hes; Kiril Trpkov
Journal:  Mod Pathol       Date:  2022-03-10       Impact factor: 8.209

Review 6.  Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.

Authors:  Alessia Cimadamore; Liang Cheng; Marina Scarpelli; Francesco Massari; Veronica Mollica; Matteo Santoni; Antonio Lopez-Beltran; Rodolfo Montironi; Holger Moch
Journal:  Transl Androl Urol       Date:  2021-03

Review 7.  Renal Cell Carcinoma in Tuberous Sclerosis Complex.

Authors:  Elizabeth P Henske; Kristine M Cornejo; Chin-Lee Wu
Journal:  Genes (Basel)       Date:  2021-10-08       Impact factor: 4.141

Review 8.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

Review 9.  Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors.

Authors:  Anna Caliò; Matteo Brunelli; Stefano Gobbo; Pedram Argani; Enrico Munari; George Netto; Guido Martignoni
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 10.  Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach.

Authors:  Reza Alaghehbandan; Delia Perez Montiel; Ana Silvia Luis; Ondrej Hes
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.